Genmab
GMAB
$28.53
Share price
-3.06%
Change (1 day)
-33.56%
Change (1 year)
Categories
Genmab (GMAB) Fails to deliver data
Key failure to deliver metrics for Genmab:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $8.06 M
- Last year FTD volume: $34.46 M
Failures to deliver for Genmab (GMAB) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Genmab (GMAB) - since 2013
Volume in USD (price x number of shares), data since 2013Genmab (GMAB) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $8.06 M | -72.07% |
| 2023 | $28.85 M | -65.73% |
| 2022 | $84.2 M | 32.68% |
| 2021 | $63.46 M | -12.17% |
| 2020 | $72.25 M | 142.93% |
| 2019 | $29.74 M | -67.15% |
| 2018 | $90.53 M | 912.76% |
| 2017 | $8.93 M | -44.25% |
| 2016 | $16.03 M | 56.67% |
| 2015 | $10.23 M | -66.34% |
| 2014 | $30.4 M | 2295.56% |
| 2013 | $1.26 M |